4ET-2124

N/A

Report date: 2023/10/08 16:40:07

NME

Base Information

Drug Name4ET-2124

Drug Alias Name4ET-21244ET2124

ClassificationSmall molecules

Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors

TargetsMAP kinase-interacting serine/threonine-protein kinase MNK1MAP kinase-interacting serine/threonine-protein kinase 2

Therapy Area/IndicationsMigraine Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator Companies4E Therapeutics Inc

China Registration ClassN/A

Develop Information

Active Companies4E Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsMigraine Disorders

Inactive IndicationsN/A

Other Information

ATC CodeN/A